Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

AGM Statement

20 Mar 2019 07:00

RNS Number : 3317T
Arden Partners plc
20 March 2019
 

Arden Partners plc

("Arden" or the "Company")

 

Annual General Meeting Statement 2019

 

 Arden Partners plc (AIM: ARDN), the institutional stockbroking company, will hold its Annual General Meeting ("AGM") at 12.30 pm today at 125 Old Broad Street, London EC2N 1AR.

 

The following statement will be made at the AGM:

 

"As predicted in the 2018 Annual Report, market conditions have remained challenging and we expect them to continue to be so in the short term.

 

Nevertheless, in the year to date we have completed a number of fundraisings and advisory transactions on behalf of our corporate clients.

 

Furthermore, we have continued to grow our corporate client base which remains key to our strategy.

 

The Company's balance sheet remains strong and despite the market challenges we have a good pipeline of corporate business."

 

For further enquiries:

 

Arden Partners plc

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited

020 7484 4040

Sam Fuller / Tim Richardson

 

 

Notes for editors

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUKVURKVAOAAR
Date   Source Headline
4th Apr 201111:50 amRNSForm 8.5 (EPT/NON-RI)
1st Apr 201111:50 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20113:44 pmRNSDirector/PDMR Shareholding
31st Mar 20113:35 pmRNSTotal Voting Rights
31st Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
30th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
29th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
28th Mar 20113:22 pmRNSAdditional Listing
28th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
22nd Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
21st Mar 20114:55 pmRNSHolding(s) in Company
21st Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 201111:55 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 201111:54 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201111:50 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201110:44 amRNSAdditional Listing
15th Mar 201111:58 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 201111:57 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 201112:00 pmRNSAnnual Report and Accounts
11th Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
1st Mar 201111:45 amRNSForm 8.5 (EPT/NON-RI)
28th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
24th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
23rd Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 20115:07 pmRNSHolding(s) in Company
22nd Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
18th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 20114:58 pmRNSTransaction in own shares and Total Voting Rights
17th Feb 201111:45 amRNSForm 8.5 (EPT/NON-RI)
16th Feb 201111:50 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 201112:37 pmRNSForm 8.5 (EPT/NON-RI)
15th Feb 201112:37 pmRNSForm 8.5 (EPT/NON-RI) (Amendment)
15th Feb 201112:35 pmRNSForm 8.5 (EPT/NON-RI) (Amendment)
14th Feb 201110:05 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20119:53 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20119:40 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20119:33 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.